The Technical AnalystExchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Pasithea Therapeutics Price, Forecast, Insider, Ratings, Fundamentals & Signals
-6.67% $0.0140
/ 17 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 8.60 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 614.43 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2024-04-17 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$13.25 (94 524.93%) $13.23 |
| Date: 2024-04-18 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0060 - 0.0220 ( +/- 57.14%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-06-30 | Currie Graeme Martin | Sell | 300 000 | Stock Option (right to buy) |
| 2022-10-17 | Steinman Lawrence | Buy | 0 | |
| 2023-06-02 | Steinman Lawrence | Buy | 30 000 | Common Stock |
| 2022-10-22 | Pd Joint Holdings, Llc Series 2016-a | Sell | 0 | Common Stock |
| 2022-12-21 | Pd Joint Holdings, Llc Series 2016-a | Sell | 800 000 | Warrant (right to buy) |
| INSIDER POWER |
|---|
| -51.79 |
| Last 25 transactions |
| Buy: 1 015 206 | Sell: 1 100 000 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0140 (-6.67% ) |
| Volume | 0.0082 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For KTTAW
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
KTTAW
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.